UK markets closed
NIKKEI 225
28,600.41 -204.44 (-0.71%) HANG SENG
26,132.03 +5.10 (+0.02%) CRUDE OIL
83.74 -0.02 (-0.02%) GOLD FUTURES
1,808.90 +12.60 (+0.70%) DOW
35,742.12 +65.10 (+0.18%) BTC-GBP
46,237.87 +2,185.44 (+4.96%)
AbbVie Inc. (ABBV)
NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
108.71-0.43 (-0.40%)
As of 1:00PM EDT. Market open.
| Previous close | 109.14 |
| Open | 109.08 |
| Bid | 108.61 x 2200 |
| Ask | 108.62 x 1000 |
| Day's range | 107.75 - 109.08 |
| 52-week range | 79.11 - 121.53 |
| Volume | 1,901,183 |
| Avg. volume | 7,141,750 |
| Market cap | 192.106B |
| Beta (5Y monthly) | 0.83 |
| PE ratio (TTM) | 29.32 |
| EPS (TTM) | 3.71 |
| Earnings date | 29 Oct 2021 |
| Forward dividend & yield | 5.20 (4.76%) |
| Ex-dividend date | 14 Oct 2021 |
| 1y target est | 127.01 |
- Simply Wall St.
Investors in AbbVie (NYSE:ABBV) have made a strong return of 138% over the past five years
The main point of investing for the long term is to make money. But more than that, you probably want to see it rise...
- Motley Fool
What Could These Clinical Results Mean for AbbVie's Shareholders?
The results from phase 3 clinical trials suggest that Rinvoq could be an effective treatment for patients.
- Zacks
AbbVie (ABBV) Earnings Expected to Grow: Should You Buy?
AbbVie (ABBV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
© 2021 Verizon Media. All rights reserved.
